Association of an anaplastic lymphoma kinase pathway signature with cell de‐differentiation, neoadjuvant chemotherapy response, and recurrence risk in breast cancer-Reference-Cited by-同舟云学术

Association of an anaplastic lymphoma kinase pathway signature with cell de‐differentiation, neoadjuvant chemotherapy response, and recurrence risk in breast cancer

Published:2020-08-21 Issue:9 Volume:40 Page:422-434
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Liu Dingxie¹,Wu Yong²³^ORCID

Affiliation:

1. Bluewater Biotech LLC New Providence Mandaluyong NJ 07974 USA

2. Division of Cancer Research and TrainingDepartment of Internal MedicineCharles R. Drew University of Medicine and Science Los Angeles CA 90059 USA

3. David Geffen UCLA School of Medicineand UCLA Jonsson Comprehensive Cancer Center Los Angeles CA 90059 USA

Funder

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cac2.12038

Reference47 articles.

1. Cancer statistics, 2019

2. The landscape of cancer genes and mutational processes in breast cancer

3. Comprehensive molecular portraits of human breast tumours

4. Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma

5. Role and targeting of anaplastic lymphoma kinase in cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. On the possibility of laser-plasma-induced depopulation of the isomer in 93Mo at ELI-NP;The European Physical Journal A;2023-11-27

2. Frequency spectrum of radiation transfer in high voltage circuit breaker arcs for polymer nozzle ablation in C₄F₇N and CO₂ gas mixture;Journal of Physics D: Applied Physics;2023-05-10

3. CTP synthase 2 predicts inferior survival and mediates DNA damage response via interacting with BRCA1 in chronic lymphocytic leukemia;Experimental Hematology & Oncology;2023-01-12

4. Expression of NOTCH1, NOTCH4, HLA-DMA and HLA-DRA is synergistically associated with T cell exclusion, immune checkpoint blockade efficacy and recurrence risk in ER-negative breast cancer;Cellular Oncology;2022-05-11

5. Brilliant glycans and glycosylation: Seq and ye shall find;International Journal of Biological Macromolecules;2021-10